TY - JOUR
T1 - Why are there so few key mutant clones? The influence of stochastic selection and blocking on affinity maturation in the germinal center
AU - Kleinstein, Steven H.
AU - Singh, Jaswinder Pal
N1 - Funding Information:
We would like to thank Martin Weigert and Yoram Louzoun for useful discussions. We would also like to thank Michael Radmacher for providing the computer code used in Radmacher et al. (9), and Garnett Kelsoe for NP sequence data. This work was supported in part by a National Science Foundation IGERT grant (DGE-9972930) and a PECASE grant (CCR-9702115), and through DIMACS.
PY - 2003/7/1
Y1 - 2003/7/1
N2 - A small number of key somatic mutations lead to high-affinity binding in the anti-hapten immune responses to 2-phenyl-5-oxazolone (phOx) and (4-hydroxy-3-nitrophenyl)acetyl (NP). Affinity maturation models of the germinal center hold that B cells carrying these key mutations are preferentially selected for expansion within the germinal centers. However, additional factors are required to account for some quantitative aspects of affinity maturation in vivo. Radmacher et al. have shown that key mutants are observed in vivo significantly less frequently than expected by these models. To account for this finding, they propose that selection is a stochastic process where key mutants may be overlooked by positive selection or recruited out of the germinal center. While acknowledging that a minimal amount of stochastic selection is probably unavoidable in the germinal center, we instead propose a structural explanation for this key mutant discrepancy. This model is based on the existence of a large number of blocking mutations whose presence can prevent the ability of key mutations to confer high-affinity binding. Using mathematical modeling and computer simulation, we show that in addition to reconciling the key mutant discrepancy, the blocking model accounts for other aspects of experimental data that are not predicted by the stochastic selection model. In particular, the blocking model is consistent with the observation that key mutants generally exhibit a higher number of mutations per sequence in the phOx response, but a lower number in the NP response.
AB - A small number of key somatic mutations lead to high-affinity binding in the anti-hapten immune responses to 2-phenyl-5-oxazolone (phOx) and (4-hydroxy-3-nitrophenyl)acetyl (NP). Affinity maturation models of the germinal center hold that B cells carrying these key mutations are preferentially selected for expansion within the germinal centers. However, additional factors are required to account for some quantitative aspects of affinity maturation in vivo. Radmacher et al. have shown that key mutants are observed in vivo significantly less frequently than expected by these models. To account for this finding, they propose that selection is a stochastic process where key mutants may be overlooked by positive selection or recruited out of the germinal center. While acknowledging that a minimal amount of stochastic selection is probably unavoidable in the germinal center, we instead propose a structural explanation for this key mutant discrepancy. This model is based on the existence of a large number of blocking mutations whose presence can prevent the ability of key mutations to confer high-affinity binding. Using mathematical modeling and computer simulation, we show that in addition to reconciling the key mutant discrepancy, the blocking model accounts for other aspects of experimental data that are not predicted by the stochastic selection model. In particular, the blocking model is consistent with the observation that key mutants generally exhibit a higher number of mutations per sequence in the phOx response, but a lower number in the NP response.
KW - (4-hydroxy-3-nitropheny)acetyl
KW - 2-phenyl-5-oxazolone
KW - Mathematical modeling
KW - Somatic hypermutation
UR - http://www.scopus.com/inward/record.url?scp=0038350799&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0038350799&partnerID=8YFLogxK
U2 - 10.1093/intimm/dxg085.sgm
DO - 10.1093/intimm/dxg085.sgm
M3 - Article
C2 - 12807826
AN - SCOPUS:0038350799
SN - 0953-8178
VL - 15
SP - 871
EP - 884
JO - International Immunology
JF - International Immunology
IS - 7
ER -